Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.

1.67 Rating by hostinfo.pw

Updated 7 year 6 month ago

WHOIS DNS Server Info Registrar Server availability Web Archive Google index

IP Address: 52.54.40.78 Hosted Country:

United States

Registration Date: 1995-05-08

Traffic Report

Daily Unique Visitors:	14,351
Daily Pageviews:	71,755

Estimated Valuation

Income Per Day:	No data
Estimated Worth:	No data

Search Engine Indexes

Google Indexed Pages:	No data
Yahoo Indexed Pages:	No data
Bing Indexed Pages:	No data

Search Engine Backlinks

Google Backlinks:	No data
Bing Backlinks:	No data
Alexa BackLinks:	No data

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	No data
WOT Trustworthiness:	Excellent
WOT Privacy:	Excellent
WOT Child Safety:	Excellent

Website Inpage Analysis

Total IFRAMEs:	1
Total Images:	3
Google Adsense:	No data
Google Analytics:	No data

Website Ranks & Scores

Alexa Rank:	102,886
PageSpeed Score:	48 out of 100
Domain Authority:	No data

Web Server Information

Hosted IP Address:

52.54.40.78

Hosted Country:

Location Latitude:

39.0437

Location Longitude:

-77.4875

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Wed, 27 Feb 2019 05:34:16 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Cache-Control: max-age=86400, public
X-Drupal-Dynamic-Cache: MISS
Link: ; rel="revision"
X-UA-Compatible: IE=edge
Content-language: en
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Last-Modified: Wed, 27 Feb 2019 04:49:38 GMT
Vary: CF-IPCountry,Accept-Encoding
X-Generator: Drupal 8 (https://www.drupal.org)
Strict-Transport-Security: max-age=1000
X-Request-ID: v-169470a6-3a4b-11e9-8584-47175c743f2f
X-AH-Environment: prod
Via: varnish
X-Cache: HIT
X-Cache-Hits: 1
CF-Cache-Status: HIT
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Server: cloudflare
CF-RAY: 4af848084e3b8e9d-DME
Content-Encoding: gzip

Domain Information

Domain Registrar:	Network Solutions, LLC
Registration Date:	1995-05-08
Last Modified:	2016-04-13

Domain Nameserver Information

Host		IP Address	Country
ns-edi.charlesriverlabs.net		194.159.178.150	United Kingdom
ns-wlm.charlesriverlabs.net		208.89.252.220	United States

DNS Record Analysis

Type	TTL	Extra
A	589	IP: 52.54.40.78
NS	3600	Target: ns-wlm.crl.com
NS	3600	Target: ns-edi.crl.com
SOA	3600	MNAME: ns-wlm.crl.com RNAME: hostmaster.crl.com Serial: 306 Refresh: 10800 Retry: 3600 Expire: 604800
MX	3600	Priority: 10 Target: criver-com.mail.protection.outlook.com
TXT	3600	TXT: v=spf1 include:spf.protection.ou tlook.com -all
TXT	3600	TXT: pardot_60962_*=8e8566641e c9d90f0508fc8a31d8c028add dbc4fa3cf513b4eaf465212f0 f1e2
TXT	3600	TXT: google-site-verification= ZqGsGxc0eBAL__q8ekLrCfdM6 xAC_IwoxLFFHPdn9QQ
TXT	3600	TXT: MS=ms72663366
TXT	3600	TXT: pardot_346371_*=21f437f52 f87af706fcaeb307505028348 2d3ad415cbad3d8b24cdf514f 7f510

Full WHOIS Lookup

Domain Name: CRIVER.COM
Registry Domain ID: 5355_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2016-04-13T16:08:23Z
Creation Date: 1995-05-08T04:00:00Z
Registry Expiry Date: 2021-05-09T04:00:00Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server:
NS-EDI.CHARLESRIVERLABS.NET
Name Server: NS-WLM.CHARLESRIVERLABS.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2019-02-27T05:34:19Z

Meta Description of criver.com

Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.

Meta Tags of criver.com

drug discovery, drug development, cro